Retour
20
27
Fourchette du Jour
8,16 €
8,16 €
Fourchette 52 Semaines
6,05 €
9,07 €
Volume
100
Moyenne 50J / 200J
7,95 €
/
7,56 €
Clôture Précédente
8,16 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 25,2 | 0,3 |
| P/B | 0,8 | 2,9 |
| ROE % | 3,4 | 3,7 |
| Net Margin % | 2,7 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
1,5 B | 0 |
Points Clés
Revenue grew 4,07% annually over 5 years — modest growth
ROE of 3,40% is below average
Debt/Equity of 0,12 — conservative balance sheet
Generating 57,20M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,92%
Cash machine — converts 131,95% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
4,07%
Revenue (1Y)8,99%
Earnings (1Y)11,98%
FCF Growth (3Y)N/A
Qualité
Return on Equity
3,40%
ROIC2,50%
Net Margin2,72%
Op. Margin3,02%
Sécurité
Debt / Equity
0,12
Current Ratio2,23
Interest Coverage14,16
Valorisation
P/E Ratio
25,20
P/B Ratio0,84
EV/EBITDA19,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,99% | Revenue Growth (3Y) | 5,04% |
| Earnings Growth (1Y) | 11,98% | Earnings Growth (3Y) | 31,31% |
| Revenue Growth (5Y) | 4,07% | Earnings Growth (5Y) | 133,79% |
| Profitability | |||
| Revenue (TTM) | 1,60B | Net Income (TTM) | 43,35M |
| ROE | 3,40% | ROA | 2,34% |
| Gross Margin | 10,77% | Operating Margin | 3,02% |
| Net Margin | 2,72% | Free Cash Flow (TTM) | 57,20M |
| ROIC | 2,50% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,23 |
| Interest Coverage | 14,16 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 25,20 | P/B Ratio | 0,84 |
| P/S Ratio | 0,68 | PEG Ratio | 1,12 |
| EV/EBITDA | 19,98 | Dividend Yield | 0,00% |
| Market Cap | 1,09B | Enterprise Value | 962,17M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,60B | 1,46B | 1,45B | 1,59B | 1,36B |
| Net Income | 43,35M | 38,71M | 25,14M | 28,30M | 1,45M |
| EPS (Diluted) | 0,34 | 0,29 | 0,19 | 0,21 | 0,01 |
| Gross Profit | 171,82M | 148,81M | 999,52M | 182,63M | 937,72M |
| Operating Income | 48,15M | 40,40M | 36,11M | 30,52M | 10,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,86B | 1,77B | 1,70B | 1,67B | 1,63B |
| Total Liabilities | 530,51M | 490,30M | 453,51M | 440,82M | 439,45M |
| Shareholders' Equity | 1,30B | 1,25B | 1,22B | 1,20B | 1,17B |
| Total Debt | 149,60M | 149,90M | 158,20M | 159,76M | 160,60M |
| Cash & Equivalents | 279,86M | 206,04M | 77,33M | 126,32M | 90,96M |
| Current Assets | 904,11M | 789,21M | 688,61M | 611,08M | 566,43M |
| Current Liabilities | 404,85M | 335,47M | 291,08M | 273,31M | 273,38M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#980 of 1052
#670 of 827
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026